{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:32:07Z","timestamp":1793712727268,"version":"4.6.1"},"reference-count":94,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1136\/bjophthalmol-2016-309376","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T03:25:27Z","timestamp":1480735527000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":180,"title":["Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention"],"prefix":"10.1136","volume":"101","author":[{"given":"S","family":"Strong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Michaelides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-309376-1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/bjo.2008.138560","article-title":"The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography","volume":"92","author":"Hajali","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bjophthalmol-2013-304082","article-title":"Macular abnormalities in Italian patients with retinitis pigmentosa","volume":"98","author":"Testa","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/IAE.0b013e31809862aa","article-title":"Prevalence of cystoid macular edema and stability in OCT retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial","volume":"28","author":"Adackapara","year":"2008","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0420.2005.00395.x","article-title":"Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"83","author":"Ozdemir","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.1136\/bjophthalmol-2016-309376-5","doi-asserted-by":"crossref","first-page":"e004015","DOI":"10.1136\/bmjopen-2013-004015","article-title":"A comparison of the causes of blindness certifications in England and Wales in working age adults (16\u201364\u2005years), 1999\u20132000 with 2009\u20132010","volume":"4","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"key":"key-10.1136\/bjophthalmol-2016-309376-6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archopht.125.6.759","article-title":"Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone","volume":"125","author":"Scorolli","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bjo.84.5.542","article-title":"Macular oedema: the role of soluble mediators","volume":"84","author":"Kent","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1002136712070","article-title":"Cellular mechanisms of blood-retinal barrier dysfunction in macular edema","volume":"97","author":"Vinores","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-9","first-page":"1057","article-title":"Polarity and the development of the outer blood-retinal barrier","volume":"12","author":"Rizzolo","year":"1997","journal-title":"Histol Histopathol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-10","first-page":"52","volume-title":"The retina and its disorders. Breakdown of the blood-Retinal Barrier","author":"Vinores","year":"2010"},{"key":"key-10.1136\/bjophthalmol-2016-309376-11","first-page":"913","article-title":"Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization","volume":"10","author":"Vinores","year":"1995","journal-title":"Histol Histopathol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bjo.62.3.183","article-title":"Immunological studies in retinitis pigmentosa associated with retinal vascular leakage","volume":"62","author":"Spalton","year":"1978","journal-title":"Br J Ophthalmol"},{"issue":"(Suppl 1)","key":"key-10.1136\/bjophthalmol-2016-309376-13","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0039-6257(02)00294-1","article-title":"Prostaglandins and cystoid macular edema","volume":"47","author":"Miyake","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archopht.1989.01070010276036","article-title":"Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes","volume":"107","author":"Enea","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1056\/NEJM199802263380917","article-title":"Treatment of cystoid macular edema with octreotide","volume":"338","author":"Kuijpers","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2016-309376-16","first-page":"850","article-title":"Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha","volume":"70","author":"Claudio","year":"1994","journal-title":"Lab Invest"},{"key":"key-10.1136\/bjophthalmol-2016-309376-17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0074-7696(02)15016-9","article-title":"Molecular mechanisms of water transport in the eye","author":"Hamann","year":"2002","journal-title":"Int Rev Cytol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00417-006-0516-y","article-title":"Muller cells as players in retinal degeneration and edema","volume":"245","author":"Reichenbach","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol Rev"},{"key":"key-10.1136\/bjophthalmol-2016-309376-20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/IAE.0000000000000010","article-title":"Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography","volume":"34","author":"Makiyama","year":"2014","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-309376-21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bjo.57.12.904","article-title":"Autoimmunity and the retina. II. Raised serum IgM levels in retinitis pigmentosa","volume":"57","author":"Rahi","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1399-0004.1978.tb01184.x","article-title":"Serum IgM in retinitis pigmentosa: a genetic study","volume":"13","author":"Spiro","year":"1978","journal-title":"Clin Genet"},{"key":"key-10.1136\/bjophthalmol-2016-309376-23","first-page":"179","article-title":"Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations","volume":"94","author":"Heckenlively","year":"1996","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.1136\/bjophthalmol-2016-309376-24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bjo.69.1.19","article-title":"Autoimmunity in hereditary retinal degeneration. I. Basic studies","volume":"69","author":"Chant","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0161-6420(03)00259-8","article-title":"Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa","volume":"110","author":"Garcia-Arumi","year":"2003","journal-title":"Ophthalmology"},{"issue":"(Suppl)","key":"key-10.1136\/bjophthalmol-2016-309376-26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0039-6257(84)90232-7","article-title":"Role of the vitreous in cystoid macular edema","volume":"28","author":"Schepens","year":"1984","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-27","first-page":"245","article-title":"Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa","volume":"5","author":"Takezawa","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archopht.1995.01100080071031","article-title":"Quantitative assessment of macular edema with optical coherence tomography","volume":"113","author":"Hee","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-9394(99)00100-2","article-title":"Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa","volume":"128","author":"Hirakawa","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-30","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.ophtha.2004.04.019","article-title":"Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa","volume":"111","author":"Apushkin","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309376-31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1167\/iovs.12-10149","article-title":"Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa","volume":"54","author":"Kim","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/eye.2008.266","article-title":"Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa","volume":"23","author":"Oishi","year":"2009","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.eye.6703076","article-title":"Correlation between visual function and photoreceptor inner\/outer segment junction in patients with retinitis pigmentosa","volume":"23","author":"Aizawa","year":"2009","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-34","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1167\/iovs.04-1383","article-title":"The association between visual acuity and central retinal thickness in retinitis pigmentosa","volume":"46","author":"Sandberg","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000233229","article-title":"Correlation of retinal sensitivity and retinal thickness in central serous chorioretinopathy","volume":"224","author":"Dinc","year":"2010","journal-title":"Ophthalmologica"},{"key":"key-10.1136\/bjophthalmol-2016-309376-36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.eye.6702014","article-title":"Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema","volume":"20","author":"Okada","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.iae.0000256658.71864.ca","article-title":"Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema","volume":"27","author":"Carpineto","year":"2007","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-38","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1167\/iovs.14-15995","article-title":"Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa","volume":"56","author":"Liew","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13816810.2011.642453","article-title":"Association of p.P347L in the rhodopsin gene with early-onset cystoid macular edema in patients with retinitis pigmentosa","volume":"33","author":"Kim","year":"2012","journal-title":"Ophthalmic Genet"},{"key":"key-10.1136\/bjophthalmol-2016-309376-40","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/IAE.0b013e31805f6b79","article-title":"Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa","volume":"27","author":"Apushkin","year":"2007","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-41","first-page":"1914","article-title":"Long-term effect of acetazolamide in a patient with retinitis pigmentosa","volume":"31","author":"Chen","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2006.107466","article-title":"Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"91","author":"Fishman","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(94)31277-2","article-title":"Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa","volume":"101","author":"Fishman","year":"1994","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309376-44","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archopht.1989.01070020519031","article-title":"Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa","volume":"107","author":"Fishman","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-45","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1993.01090120062023","article-title":"Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa","volume":"111","author":"Fishman","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-46","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa","volume":"141","author":"Grover","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00006982-199705000-00009","article-title":"Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa","volume":"17","author":"Grover","year":"1997","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00417-011-1904-5","article-title":"The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa","volume":"250","author":"Ikeda","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-50","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2012-303005","article-title":"Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa","volume":"97","author":"Ikeda","year":"2013","journal-title":"Br J Ophthalmol\u03b3"},{"key":"key-10.1136\/bjophthalmol-2016-309376-51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00919100","article-title":"Long-term treatment of retinitis pigmentosa with acetazolamide. A pilot study","volume":"231","author":"Orzalesi","year":"1993","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4137\/OED.S13617","article-title":"Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports","volume":"6","author":"Pacella","year":"2014","journal-title":"Ophthalmol Eye Dis."},{"key":"key-10.1136\/bjophthalmol-2016-309376-53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IAE.0b013e3181e587f9","article-title":"The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis","volume":"31","author":"Thobani","year":"2011","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9394(61)91315-0","article-title":"The localization of diamox-S35 in the rabbit eye","volume":"51","author":"Goren","year":"1961","journal-title":"Am J Ophthalmol."},{"key":"key-10.1136\/bjophthalmol-2016-309376-55","first-page":"323","article-title":"Diseases of the head and neck","volume-title":"Conn's current therapy 2015","author":"Lin APO-N, S","year":"2015"},{"key":"key-10.1136\/bjophthalmol-2016-309376-56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.2000.01316.x","article-title":"Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration","volume":"121","author":"Penfold","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-58","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","article-title":"Noninfectious endophthalmitis associated with intravitreal triamcinolone injection","volume":"121","author":"Roth","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-59","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy","volume":"131","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3928\/23258160-20140131-03","article-title":"The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review","volume":"45","author":"Ahn","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.1136\/bjophthalmol-2016-309376-61","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00417-013-2447-8","article-title":"Unilateral intravitreal dexamethasone implant for bilateral retinitis pigmentosa-related macular edema","volume":"251","author":"Alhassan","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-62","first-page":"591681","article-title":"Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema","volume":"2013","author":"Barge","year":"2013","journal-title":"Case Rep Ophthalmol Med"},{"key":"key-10.1136\/bjophthalmol-2016-309376-63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/S0004-27492013000600013","article-title":"[Intravitreal implantation of Ozurdex(R) chronic delivery system for management of macular edema related to retinitis pigmentosa: case report]","volume":"76","author":"Buchaim","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-64","first-page":"1","article-title":"Deflazacort treatment of cystoid macular edema in patients affected by retinitis pigmentosa: a pilot study","volume":"6","author":"Giusti","year":"2002","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-65","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.iae.0000254897.86389.a5","article-title":"Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"26","author":"Kim","year":"2006","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-66","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/112067210601600620","article-title":"Optical coherence tomography and focal electroretinogram evaluation of cystoid macular edema secondary to retinitis pigmentosa treated with intravitreal triamcinolone: case report","volume":"16","author":"Minnella","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/eye.2013.314","article-title":"Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant","volume":"28","author":"Patil","year":"2014","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2016-309376-68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000350544","article-title":"Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema","volume":"4","author":"Saatci","year":"2013","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4615-0067-4_10","article-title":"Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report","volume":"533","author":"Sallum","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-70","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/1542-8877-20030901-11","article-title":"Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide","volume":"34","author":"Saraiva","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.1136\/bjophthalmol-2016-309376-71","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jcjo.2015.12.021","article-title":"Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide","volume":"51","author":"Schaal","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-72","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00417-012-2249-4","article-title":"Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa","volume":"251","author":"Srour","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/ICB.0b013e318150d705","article-title":"Subretinal triamcinolone acetonide associated with improvement of cystoid macular edema in a patient with retinitis pigmentosa","volume":"3","author":"Urban","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.1136\/bjophthalmol-2016-309376-74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/0-387-32442-9_43","article-title":"Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases","volume":"572","author":"Wang","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-75","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309376-76","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6","volume":"127","author":"Scott","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICB.0b013e31825a300f","article-title":"Topical steroidal and nonsteroidal antiinflammatory drugs for the treatment of cystoid macular edema in retinitis pigmentosa","volume":"7","author":"Park","year":"2013","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.1136\/bjophthalmol-2016-309376-78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000368052","article-title":"Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome","volume":"233","author":"Lemos Reis","year":"2015","journal-title":"Ophthalmologica"},{"key":"key-10.1136\/bjophthalmol-2016-309376-79","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ophtha.2011.02.039","article-title":"Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration","volume":"118","author":"Brown","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309376-80","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1167\/iovs.07-1168","article-title":"Aqueous humor levels of vascular endothelial growth factor in retinitis pigmentosa","volume":"49","author":"Salom","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10792-007-9175-1","article-title":"Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa","volume":"29","author":"Querques","year":"2009","journal-title":"Int Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-82","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/02713680802710692","article-title":"Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa","volume":"34","author":"Yuzbasioglu","year":"2009","journal-title":"Curr Eye Res"},{"key":"key-10.1136\/bjophthalmol-2016-309376-83","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jop.2009.0089","article-title":"Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"25","author":"Artunay","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2016-309376-84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12886-015-0033-z","article-title":"Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa\u2014a first case report and short review of the literature","volume":"15","author":"Moustafa","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-85","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000448427","article-title":"Treatment of retinitis pigmentosa-associated cystoid macular oedema using intravitreal aflibercept (Eylea) despite minimal response to ranibizumab (Lucentis): a case report","volume":"7","author":"Strong","year":"2016","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ICB.0b013e3181af7b6c","article-title":"Treatment of retinitis pigmentosa-related cystoid macular edema with intravitreous ranibizumab","volume":"4","author":"Shah","year":"2010","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.1136\/bjophthalmol-2016-309376-87","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000351681","article-title":"Spectral domain optical coherence tomography findings in patients with retinitis pigmentosa","volume":"50","author":"Triolo","year":"2013","journal-title":"Ophthalmic Res"},{"key":"key-10.1136\/bjophthalmol-2016-309376-88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/jop.2011.0140","article-title":"Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab","volume":"28","author":"Battaglia Parodi","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2016-309376-89","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10792-009-9337-4","article-title":"Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab","volume":"30","author":"Malik","year":"2010","journal-title":"Int Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0420.2006.00872.x","article-title":"Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa","volume":"85","author":"Melo","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.1136\/bjophthalmol-2016-309376-91","first-page":"1873","article-title":"Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome","volume":"42","author":"Aleman","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309376-92","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamaophthalmol.2014.1726","article-title":"The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema","volume":"132","author":"Sandberg","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9394(14)74221-7","article-title":"Grid photocoagulation for macular edema in patients with retinitis pigmentosa","volume":"103","author":"Newsome","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309376-94","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0420.2001.790502.x","article-title":"The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology","volume":"79","author":"Stefansson","year":"2001","journal-title":"Acta Ophthalmol Scand"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-309376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T03:29:04Z","timestamp":1657942144000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-309376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,14]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/bjophthalmol-2016-309376"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309376","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}